U.S. Army supports Palmer's research
Posted:
Andre Palmer’s research on polymerized hemoglobins for use in transfusion medicine has attracted the attention of the U.S. Army.
The Army’s $2.4M grant will support the development of an oxygen therapeutic with the potential to save soldiers’ lives by enabling on-site administration of a form of artificial blood that could sustain a wounded soldier for up to 24 hours until more comprehensive care can be provided at a medical facility.
The funding builds on $8.4M received in NIH R01 funding earlier in 2017.
